The effect on lymphocyte subsets of decreasing/stopping tyrosine kinase inhibitor therapy in chronic myeloid leukaemia: data from the DESTINY trial

British Journal of Haematology, EarlyView.

Source: British Journal of Haematology - November 8, 2018 Category: Hematology Authors: Gemma M. Austin, Katy Knight, Joanne Bell, Anthony Carter, Earnest Heartin, David Watson, Letizia Foroni, Stephen E. Christmas, Fotios Polydoros, Richard E. Clark Tags: Correspondence Source Type: research